- Home
- ISTR vs PROK Comparison
ISTR vs PROK Comparison
Compare ISTR & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISTR
- PROK
- Stock Information
- Founded
- ISTR 2006
- PROK 2015
- Country
- ISTR United States
- PROK United States
- Employees
- ISTR N/A
- PROK N/A
- Industry
- ISTR Major Banks
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ISTR Finance
- PROK Health Care
- Exchange
- ISTR Nasdaq
- PROK Nasdaq
- Market Cap
- ISTR 225.8M
- PROK 212.4M
- IPO Year
- ISTR 2014
- PROK N/A
- Fundamental
- Price
- ISTR $20.30
- PROK $1.80
- Analyst Decision
- ISTR
- PROK Buy
- Analyst Count
- ISTR 0
- PROK 5
- Target Price
- ISTR N/A
- PROK $4.50
- AVG Volume (30 Days)
- ISTR 31.7K
- PROK 537.9K
- Earning Date
- ISTR 01-27-2025
- PROK 11-12-2024
- Dividend Yield
- ISTR 2.04%
- PROK N/A
- EPS Growth
- ISTR N/A
- PROK N/A
- EPS
- ISTR 1.79
- PROK N/A
- Revenue
- ISTR $82,729,000.00
- PROK N/A
- Revenue This Year
- ISTR N/A
- PROK N/A
- Revenue Next Year
- ISTR $12.80
- PROK N/A
- P/E Ratio
- ISTR $11.24
- PROK N/A
- Revenue Growth
- ISTR N/A
- PROK N/A
- 52 Week Low
- ISTR $14.60
- PROK $1.18
- 52 Week High
- ISTR $24.81
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- ISTR 42.39
- PROK 53.24
- Support Level
- ISTR $19.37
- PROK $1.50
- Resistance Level
- ISTR $20.17
- PROK $1.82
- Average True Range (ATR)
- ISTR 0.63
- PROK 0.14
- MACD
- ISTR 0.04
- PROK 0.01
- Stochastic Oscillator
- ISTR 47.81
- PROK 76.14
About ISTR Investar Holding Corporation
Investar Holding Corp is a us-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.